![]() |
![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
![]() |
Preclinical in vivo imaging services. |
|
|
Custom human
and murine monoclonal antibodies and immunotechnology services. |
|
|
|
![]() |
Cleantech specializing in biomaterials. |
|
|
Cytoo
develops high tech culture substrates for cell analysis
and High Content Screening. By controlling the geometry
of the cell’s
microenvironment, Cytoo’s
technology enables robust and sensitive quantification
of cell phenotypes. |
|
|
|
![]() |
Discovery and development of novel small molecule drugs that are intended as cancer therapies. |
|
|
Provide data analysis services, software and databases for microbial research. |
|
|
|
Immunomonitoring plateform services for diagnostic of the
immune forecast. |
|
|
|
Research and production of polysaccharides and fine chemical
reagents. |
|
|
|
![]() |
A new therapeutic & diagnostic strategy to combat diabetes. |
|
|
| Clinical Research Organisation specialising in the conduct
of clinical studies and particularly in early drug development. |
|
|
|
![]() |
Smartox give access to an immense library of bioactive peptides. |
|
|
![]() |
Conception, fabrication et commercialisation de réactifs pour le diagnostic in-vitro. |
|
|
![]() |
Innovative services for pre-clinical studies of CNS therapeutics. |
|
|
![]() |
Membrane protein development and production for Drug Discovery and innovative therapeutic and vaccine approaches. |





ADEBAG 5 Avenue du Grand Sablon, 38700 LA TRONCHE FRANCE | Tel : +33 (0)4 76 54 95 63 | Fax : +33 (0)4 76 54 95 61